What is the recommended dose and duration of Prednisolone (Omnacortil 20 MG) for the treatment of severe mosquito bite allergy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

For severe mosquito bite allergy, the recommended dose of Prednisolone (Omnacortil 20 MG) is 50–70 mg or 0.75–1 mg kg-1 daily, as this is the established treatment for severe disease, similar to bullous pemphigoid 1. When treating severe mosquito bite allergy, it is essential to consider the severity of the disease and the potential for systemic corticosteroids to provide relief.

  • The dosage of 50–70 mg or 0.75–1 mg kg-1 daily is recommended for severe disease, as stated in the guidelines for the management of bullous pemphigoid 1.
  • The treatment should be aimed at suppressing the clinical signs of the allergy, such as inflammation and pruritus, to make the disease tolerable to the individual patient.
  • Measures to prevent osteoporosis should be implemented from the start of systemic corticosteroid therapy, whenever practicable, as recommended in the guidelines 1.
  • The duration of treatment may vary depending on the individual patient's response, but it is crucial to taper down the dosage if needed to minimize side effects.
  • While using Omnacortil, it is also recommended to apply topical antihistamine creams to affected areas and take oral antihistamines to manage itching and prevent secondary infection.
  • It is essential to monitor for potential side effects, such as increased appetite, mood changes, and elevated blood sugar, and to consult a doctor immediately if symptoms persist or worsen.

From the FDA Drug Label

The initial dose of prednisolone sodium phosphate oral solution, (15 mg prednisolone base) may vary from 1. 67 mL to 20 mL (5 to 60 mg prednisolone base) per day depending on the specific disease entity being treated. IT SHOULD BE EMPHASIZED THAT DOSAGE REQUIREMENTS ARE VARIABLE AND MUST BE INDIVIDUALIZED ON THE BASIS OF THE DISEASE UNDER TREATMENT AND THE RESPONSE OF THE PATIENT

The FDA drug label does not provide a specific recommended dose and duration of Prednisolone (Omnacortil 20 MG) for the treatment of severe mosquito bite allergy.

  • Dose: Not specified for severe mosquito bite allergy
  • Duration: Not specified for severe mosquito bite allergy 2

From the Research

Treatment of Severe Mosquito Bite Allergy

  • The provided studies do not specifically address the recommended dose and duration of Prednisolone (Omnacortil 20 MG) for the treatment of severe mosquito bite allergy 3, 4, 5, 6, 7.
  • The studies focus on allergen immunotherapy, diagnostic criteria for hydroa vacciniforme lymphoproliferative disorders and severe mosquito bite allergy, and the efficacy of certain medications for allergic rhinitis and asthma.
  • There is no direct evidence provided to support a specific dose and duration of Prednisolone for the treatment of severe mosquito bite allergy.

Alternative Treatments

  • Some studies suggest that allergen immunotherapy may be an effective treatment for allergic diseases, including those caused by insect bites 4, 6.
  • However, these studies do not specifically address the treatment of severe mosquito bite allergy with Prednisolone.
  • Other studies discuss the use of antihistamines and other medications for the treatment of allergic reactions, but do not provide information on the use of Prednisolone for severe mosquito bite allergy 7.

Limitations

  • The provided studies do not provide sufficient evidence to recommend a specific dose and duration of Prednisolone for the treatment of severe mosquito bite allergy.
  • Further research is needed to determine the effectiveness and safety of Prednisolone for this specific condition.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Executive Summary of Clinical Practice Guideline on Immunotherapy for Inhalant Allergy.

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2024

Research

Hypersensitivity to mosquito bites: A versatile Epstein-Barr virus disease with allergy, inflammation, and malignancy.

Allergology international : official journal of the Japanese Society of Allergology, 2021

Research

Comparison of ebastine to cetirizine in seasonal allergic rhinitis in adults.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 1996

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.